Yogesh Saini
Bio
Dr. Saini received his DVM (1996-2001) from College of Veterinary Sciences, Palampur (India) and MVSc in Veterinary Biochemistry and Biotechnology (2001-2003) from College of Veterinary Sciences, Pantnager (India). Thereafter, he completed a Senior Research Fellowship (2003-2005) at Indian Veterinary Research Institute, Izatnagar (India). He received a dual-PhD (Genetics and Toxicology) under the supervision of Dr. John LaPres at Michigan State University in 2009. After completing postdoctoral training (2010-2014) in the laboratory of Dr. Richard Boucher at the University of North Carolina (UNC), he was promoted to the rank of research instructor at Marsico Lung Institute. He then joined LSU/SVM in 2014 as a tenure-track Assistant Professor. In 2019, he received early tenure with promotion to Associate Professor. Most recently in August 2023, he joined NCSU/CVM as full professor in the department of Population Health and Pathobiology.
Area(s) of Expertise
Lung Inflammation, Macrophage Biology, Inhalation Toxicology, Hepatotoxicity
Publications
- The NLRP3 Inflammasome Is Dispensable in Methicillin-Resistant Staphylococcus aureus Urinary Tract Infection , PATHOGENS (2024)
- Acute and Repeated Ozone Exposures Differentially Affect Circadian Clock Gene Expression in Mice. , Advanced biology (2023)
- Airway epithelial cell-specific deletion of HMGB1 exaggerates inflammatory responses in mice with muco-obstructive airway disease. , Frontiers in immunology (2023)
- Caveolin-1-derived peptide attenuates cigarette smoke-induced airway and alveolar epithelial injury. , American journal of physiology. Lung cellular and molecular physiology (2023)
- Activating transcription factor 6 protects against endothelial barrier dysfunction. , Cellular signalling (2022)
- Case report: Mafb promoter activity may define the alveolar macrophage dichotomy. , Frontiers in immunology (2022)
- Higher susceptibility of males to bleomycin-induced pulmonary inflammation is associated with sex-specific transcriptomic differences in myeloid cells. , Toxicology and applied pharmacology (2022)
- In Vitro Screening Method for Characterization of Macrophage Activation Responses. , Methods and protocols (2022)
- Induction of whole-body gene deletion via R26-regulated tamoxifen-inducible Cre recombinase activity. , Frontiers in pharmacology (2022)
- NLRP3 inflammasome is dispensable in methicillin resistantStaphylococcus aureusurinary tract infection , (2022)